The relevance of VCP mutations for the onset and the progression of multisystemic degenerative diseases such as IBMPFD, ALS, Parkinson’s disease, or MFMs has been demonstrated by many in vitro and in vivo studies. This evidence concerns the gene VCP and Parkinson disease.